The screening of Duchenne muscular dystrophy patients for submicroscopic deletions.
AUTOR(ES)
Hart, K
RESUMO
We have probed the DNA of 156 Duchenne muscular dystrophy (DMD) patients, representing 140 kindreds, with cloned DNA sequences derived from Xp21 and known to show deletions in some DMD patients. Sixteen cases showed a deletion, as defined by lack of hybridisation to one or more of the four probes used. However, two of these cases were brothers, so 15 independent deletions (10.7%) are represented. The deletion map is compatible with the suggested order for the sites of the probes used in the study, that is, telomere----pERT87.15----pERT87.8----pERT87.1----pX J1.1----754----centromere. Further mapping of these deletions and characterisation of the deletion breakpoints should facilitate more accurate molecular localisation of the gene or genes which, when mutated, are responsible for causing DMD.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1049832Documentos Relacionados
- Screening for Duchenne muscular dystrophy.
- Direct PCR from CVS and blood lysates for detection of cystic fibrosis and Duchenne muscular dystrophy deletions.
- Feasibility of neonatal screening for Duchenne muscular dystrophy.
- Impact of genetic counselling after neonatal screening for Duchenne muscular dystrophy.
- Deletions of fetal and adult muscle cDNA in Duchenne and Becker muscular dystrophy patients.
